Tenaya Therapeutics (TNYA) Total Liabilities (2020 - 2026)

Tenaya Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $28.9 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 17.61% year-over-year to $28.9 million; the TTM figure through Mar 2026 stood at $28.9 million (up 17.61% YoY), while the FY2025 annual figure was $23.7 million, down 12.66% from the prior year.
• Total Liabilities was $28.9 million for Q1 2026 at Tenaya Therapeutics, up from $23.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $35.6 million in Q4 2022 to a low of $22.1 million in Q3 2025.
• Historically, Total Liabilities has averaged $28.4 million across 5 years, with a median of $28.9 million in 2026.
• Biggest YoY gain for Total Liabilities was 29.83% in 2022; the steepest drop was 65.51% in 2022.
• A 5-year view of Total Liabilities shows it stood at $35.6 million in 2022, then decreased by 12.59% to $31.1 million in 2023, then dropped by 12.88% to $27.1 million in 2024, then declined by 12.66% to $23.7 million in 2025, then increased by 22.09% to $28.9 million in 2026.
• The last three Total Liabilities figures came in at $28.9 million (Q1 2026), $23.7 million (Q4 2025), and $22.1 million (Q3 2025), per Business Quant data.